[1st experience with vinblastine therapy in lymphogranulomatosis as based on clinical and lymphographic control examinations].
D000293:Adolescent; D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008220:Lymphography; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013131:Spine / Q000000981:diagnostic imaging; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use*
D014747:Vinblastine; D003520:Cyclophosphamide; D011241:Prednisone
Erste Erfahrungen mit der Vinblastintherapie der Lymphogranulomatose an Hand klinischer und lymphographischer Verlaufskontrollen.